Browsing Tag
Insilico Medicine Cayman TopCo
2 posts
Insilico Medicine’s AI drug enters Phase III dosing. Can rentosertib clear the real test?
Insilico Medicine has dosed the first patient in its 320-patient Phase III GENESIS-IPF-3 study, moving rentosertib from an intriguing AI-drug discovery milestone into a year-long test of whether its earlier lung-function signal can survive pivotal clinical scrutiny.
Takeda is paying Insilico $600m to find drugs before humans take over
Takeda signs a $600 million Insilico AI drug deal. Read how Pharma.AI could reshape pipeline economics, R&D productivity and investor sentiment.